Literature DB >> 15972045

Randomized prospective controlled trial of lateral internal sphincterotomy versus injection of botulinum toxin for the treatment of idiopathic fissure in ano.

Harish Iswariah1, Jacqueline Stephens, Nicholas Rieger, David Rodda, Peter Hewett.   

Abstract

BACKGROUND: Chronic anal fissure is a significant cause of morbidity. Internal sphincterotomy has long been the operative treatment of choice. Concerns remain, however, on its effects on continence. Botulinum toxin has been used as an agent for chemical sphincterotomy, causing temporary alleviation of sphincter spasm and allowing the fissure to heal. The aim of the present study was to compare the results of sphincterotomy to botulinum toxin.
METHODS: The study was designed as a randomized controlled trial. All adult patients over the age of 18 with chronic idiopathic fissure in ano who had failed conservative treatment were included in the trial. Patients were randomized to receive either Botox or sphincterotomy. Pain, healing of fissure and continence scores were the outcomes assessed.
RESULTS: A total of 38 patients were studied. Seventeen patients were randomized to receive Botox and 21, sphincterotomy. Patients in the Botox group were found to have significantly higher 2-week pain scores and reoperation rates, and poor healing. Continence scores were not significantly different in the two groups.
CONCLUSION: Sphincterotomy gives better results than Botox in the treatment of fissure. Botox, however, is safe with no complications and no detriment to continence and could be used in certain situations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15972045     DOI: 10.1111/j.1445-2197.2005.03427.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  17 in total

1.  Anal fissure.

Authors:  Karen N Zaghiyan; Phillip Fleshner
Journal:  Clin Colon Rectal Surg       Date:  2011-03

2.  Botulinum toxin injection versus lateral internal sphincterotomy for the treatment of chronic anal fissure: randomized prospective controlled trial.

Authors:  Neda Valizadeh; Niloufar Yahyapour Jalaly; Mohsen Hassanzadeh; Fereshteh Kamani; Zohreh Dadvar; Shapour Azizi; Babak Salehimarzijarani
Journal:  Langenbecks Arch Surg       Date:  2012-03-20       Impact factor: 3.445

Review 3.  Controversies in the treatment of common anal problems.

Authors:  Ismail Sagap; Feza-H Remzi
Journal:  World J Gastroenterol       Date:  2006-05-28       Impact factor: 5.742

Review 4.  A review of chronic anal fissure management.

Authors:  E E Collins; J N Lund
Journal:  Tech Coloproctol       Date:  2007-08-03       Impact factor: 3.781

Review 5.  Systematic review and meta-analysis of randomized controlled trials comparing botulinum toxin injection with lateral internal sphincterotomy for chronic anal fissure.

Authors:  Wan-Jin Shao; Guo-Chun Li; Zhi-Kun Zhang
Journal:  Int J Colorectal Dis       Date:  2009-03-06       Impact factor: 2.571

Review 6.  Botulinum toxin and anal fissure: efficacy and safety systematic review.

Authors:  Eugenia Yiannakopoulou
Journal:  Int J Colorectal Dis       Date:  2011-08-06       Impact factor: 2.571

Review 7.  Anal fissure (chronic).

Authors:  Rick Nelson
Journal:  BMJ Clin Evid       Date:  2010-03-24

Review 8.  Anal fissure (chronic).

Authors:  Richard L Nelson
Journal:  BMJ Clin Evid       Date:  2014-11-12

Review 9.  Botulinum toxin injection versus lateral internal sphincterotomy for chronic anal fissure: a meta-analysis of randomized control trials.

Authors:  H-L Chen; X-B Woo; H-S Wang; Y-J Lin; H-X Luo; Y-H Chen; C-Q Chen; J-S Peng
Journal:  Tech Coloproctol       Date:  2014-02-06       Impact factor: 3.781

10.  Pharmacological sphincterotomy for chronic anal fissures by botulinum toxin a.

Authors:  Uwe Wollina
Journal:  J Cutan Aesthet Surg       Date:  2008-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.